UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Downregulation of homologous recombination DNA repair genes by HDAC inhibition in prostate cancer is mediated through the E2F1 transcription factor

PloS one, 2010-06, Vol.5 (6), p.e11208

2010

Volltextzugriff (PDF)

Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors

Epigenetics, 2013-09, Vol.8 (9), p.907-920

2013

Volltextzugriff (PDF)

A Multiple-Loop, Double-Cube Microarray Design Applied to Prostate Cancer Cell Lines with Variable Sensitivity to Histone Deacetylase Inhibitors

Clinical cancer research, 2008-11, Vol.14 (21), p.6886-6894

2008

Volltextzugriff (PDF)

Targeting prostate cancer cell lines with polo‐like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors

The FASEB journal, 2013-10, Vol.27 (10), p.4279-4293

2013

Volltextzugriff (PDF)

Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo

The Prostate, 2007-07, Vol.67 (10), p.1099-1110

2007

Volltextzugriff (PDF)

Are we ready for widespread implementation of lactate POCT in fetal blood sampling? An analytical and clinical verification of the novel statstrip POCT analyzer

Practical laboratory medicine, 2024-03, Vol.39, p.e00375-e00375, Article e00375

2024

Volltextzugriff (PDF)

Acetylation and histone deacetylase inhibitors in cancer

Analytical cellular pathology (Amsterdam), 2006, Vol.28 (5-6), p.191-222

2006

Volltextzugriff (PDF)

Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo

Molecular cancer therapeutics, 2009-04, Vol.8 (4), p.802-808

2009

Volltextzugriff (PDF)

Combining the pan‐aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer

Cancer medicine (Malden, MA), 2014-10, Vol.3 (5), p.1322-1335

2014

Volltextzugriff (PDF)

Hybrids of aneuploid human cancer cells permit complementation of simple and complex cancer defects

Cancer biology & therapy, 2009-02, Vol.8 (4), p.347-355

2009

Volltextzugriff (PDF)

Shock in pregnancy: foetal distress may be the first symptom

Nederlands tijdschrift voor geneeskunde, 2014, Vol.158 (1), p.A6606

2014

Volltextzugriff (PDF)

Anaphylaxis after iron dextran administration in a pregnant woman

Nederlands tijdschrift voor geneeskunde, 2012, Vol.156 (48), p.A5264

2012

Volltextzugriff (PDF)

Differentiation Agents and Epigenomic Therapies: An Overview and Potential Use for Prostate Cancer

Prostate Cancer, 2007, p.411-443

2007

Volltextzugriff (PDF)

1 – 13 von 13

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(10)
Mit Volltextzugriff
(11)

Publikationsform

Artikel
(12)
Buchkapitel
(1)

Sprache

Englisch
(11)
Niederländisch
(2)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Downregulation of homologous recombination DNA repair genes by HDAC inhibition in prostate cancer is mediated through the E2F1 transcription factor

Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors

A Multiple-Loop, Double-Cube Microarray Design Applied to Prostate Cancer Cell Lines with Variable Sensitivity to Histone Deacetylase Inhibitors

Targeting prostate cancer cell lines with polo‐like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors

Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo

Are we ready for widespread implementation of lactate POCT in fetal blood sampling? An analytical and clinical verification of the novel statstrip POCT analyzer

Acetylation and histone deacetylase inhibitors in cancer

Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo

Combining the pan‐aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer

Hybrids of aneuploid human cancer cells permit complementation of simple and complex cancer defects

Shock in pregnancy: foetal distress may be the first symptom

Anaphylaxis after iron dextran administration in a pregnant woman

Differentiation Agents and Epigenomic Therapies: An Overview and Potential Use for Prostate Cancer

Suchergebnisse filtern